Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P250028/S001

Synergy Disc

Synergy Spine Solutions, Inc. · Decision date Apr 9, 2026

FDA DECISIONP250028/S001

What did the FDA approve?

FDA records P250028/S001 as a supplement to PMA P250028, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Apr 9, 2026.

FDA approval order statement

approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P250028
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Orthopedic
Decision date
Apr 9, 2026
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P250028/S001
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
APPR
Decision date
Apr 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

For the original device and its historical approval scope, see PMA P250028. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P250028/S001 received

    Application receipt date recorded by FDA.

  2. P250028/S001 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P250028. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250028

Product / regulatory recordCompanyPathwayDecision dateSource
Synergy Spine Solutions, Inc.PMA approvalFeb 26, 2026FDA
Synergy DiscP250028/S002
Synergy Spine Solutions, Inc.PMA supplementJul 6, 2026FDA
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA
Spineart USA, Inc.PMA supplementAug 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Synergy Spine Solutions, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
357 S. Mccaslin Blvd., Suite 120, Louisville, CO, 80027

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records